Steven Grant
Impact in
- Hematology top 0.1%
- Acute Myeloid Leukemia Research
- Molecular Biology top 0.1%
- Histone Deacetylase Inhibitors Research
- Cell death mechanisms and regulation
- Protein Degradation and Inhibitors
- Sphingolipid Metabolism and Signaling
- Ubiquitin and proteasome pathways
Papers in
-
- Cell death mechanisms and regulation 100
- Histone Deacetylase Inhibitors Research 99
- Protein Degradation and Inhibitors 66
- Ubiquitin and proteasome pathways 48
- Hematology 144
- Acute Myeloid Leukemia Research 85
- Multiple Myeloma Research and Treatments 42
- Co-authors
- Paul Dent (167 shared papers)Yun Dai (94 shared papers)Mohamed Rahmani (74 shared papers)W. David Jarvis (24 shared papers)Roberto R. Rosato (24 shared papers)Paul B. Fisher (54 shared papers)Jorge A. Almenara (19 shared papers)Adly Yacoub (40 shared papers)
- Journals
- Blood (79 papers)Molecular Pharmacology (31 papers)Cancer Biology & Therapy (26 papers)Molecular Cancer Therapeutics (21 papers)Cancer Research (21 papers)
- Partner nations
- United StatesRussiaCanada
In The Last Decade
Steven Grant
447 papers receiving 22.9k citations
Steven Grant's Hit Papers
Peers
Comparison fields: 5 of 145
- Hematology 3.3k
- Molecular Biology 15.7k
- Oncology 5.6k
- Cancer Research 2.1k
- Genetics 1.4k
Countries citing papers authored by Steven Grant
This map shows the geographic impact of Steven Grant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Grant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Grant more than expected).
Fields of papers citing papers by Steven Grant
This network shows the impact of papers produced by Steven Grant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Grant. The network helps show where Steven Grant may publish in the future.
Co-authors
The 25 scholars most cited alongside Steven Grant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 453 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis Hit paper breakdown → | 1996 | 1612 |
| 2 | MAPK pathways in radiation responses Hit paper breakdown → | 2003 | 527 |
| 3 | 1994 | 402 | |
| 4 | The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. | 2003 | 401 |
| 5 | 2003 | 392 | |
| 6 | 2010 | 350 | |
| 7 | 2006 | 346 | |
| 8 | Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. | 1994 | 327 |
| 9 | 2007 | 317 | |
| 10 | 2004 | 312 | |
| 11 | 2000 | 260 | |
| 12 | 2005 | 244 | |
| 13 | 1999 | 244 | |
| 14 | 2002 | 234 | |
| 15 | 2014 | 224 | |
| 16 | 2003 | 219 | |
| 17 | 2005 | 206 | |
| 18 | 2008 | 204 | |
| 19 | 2007 | 200 | |
| 20 | Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells. | 2003 | 196 |
About Steven Grant
Steven Grant is a scholar working on Molecular Biology, Hematology, Oncology, Genetics and Epidemiology, having authored 453 papers that have together received 23.3k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (100 papers), Histone Deacetylase Inhibitors Research (99 papers), Acute Myeloid Leukemia Research (85 papers), Protein Degradation and Inhibitors (66 papers), Cancer-related Molecular Pathways (51 papers), Ubiquitin and proteasome pathways (48 papers), Multiple Myeloma Research and Treatments (42 papers) and Chronic Lymphocytic Leukemia Research (36 papers). The work is most often cited by research in Hematology (3.3k citations), Molecular Biology (15.7k citations), Oncology (5.6k citations), Cancer Research (2.1k citations) and Genetics (1.4k citations). Steven Grant has collaborated with scholars based in United States, Russia and Canada. Frequent co-authors include Paul Dent, Yun Dai, Mohamed Rahmani, W. David Jarvis, Roberto R. Rosato, Paul B. Fisher, Jorge A. Almenara, Adly Yacoub, Xin‐Yan Pei and Richard Kolesnick. Their work appears in journals such as Blood, Molecular Pharmacology, Cancer Biology & Therapy, Molecular Cancer Therapeutics and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.